Disease progression modeling of the North Star Ambulatory Assessment for Duchenne Muscular Dystrophy
Abstract Duchenne muscular dystrophy (DMD) is a rare genetic disorder caused by decreased or absent dystrophin gene leading to progressive muscle degeneration and weakness in young boys. Disease progression models for the North Star Ambulatory Assessment (NSAA), a functional measurement widely used...
Main Authors: | Jennifer E. Hibma, Priya Jayachandran, Srividya Neelakantan, Lutz O. Harnisch |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-03-01
|
Series: | CPT: Pharmacometrics & Systems Pharmacology |
Online Access: | https://doi.org/10.1002/psp4.12921 |
Similar Items
-
Revised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular Dystrophy.
by: Eugenio Mercuri, et al.
Published: (2016-01-01) -
Categorising trajectories and individual item changes of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy.
by: Francesco Muntoni, et al.
Published: (2019-01-01) -
Determining minimal clinically important differences in the North Star Ambulatory Assessment (NSAA) for patients with Duchenne muscular dystrophy
by: Vandana Ayyar Gupta, et al.
Published: (2023-01-01) -
Determining minimal clinically important differences in the North Star Ambulatory Assessment (NSAA) for patients with Duchenne muscular dystrophy.
by: Vandana Ayyar Gupta, et al.
Published: (2023-01-01) -
Exploring the relationship between North Star Ambulatory Assessment and Health Utilities Index scores in Duchenne muscular dystrophy
by: Ivana Audhya, et al.
Published: (2023-07-01)